Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

7.37
Delayed Data
As of Aug 28
 +0.17 / +2.36%
Today’s Change
5.92
Today|||52-Week Range
22.55
-26.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization90.0K10.0K10.0K8.0K
 
 
 
 
 
 
Operating ExpensesGross Income-90.0K-10.0K-10.0K-8.0K
 
 
 
 
 
General Expenses7.3M7.4M8.5M7.8M
 
 
 
 
 
Research And Development6.1M5.8M7.3M6.5M
 
 
 
 
 
Total Operating Expenses7.4M7.4M8.5M7.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.4M-7.4M-8.5M-7.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.4M-7.4M-8.5M-7.8M
 
 
 
 
 
Net Income-7.4M-7.4M-8.5M-7.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.3M24.2M24.3M24.3M
 
 
 
 
 
Shares To Calculate EPS Diluted23.3M24.2M24.3M24.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.32-$0.31-$0.35-$0.32
 
 
 
 
 
EPS Diluted-$0.32-$0.31-$0.35-$0.32